These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pharmacodynamic monitoring of mammalian target of rapamycin inhibition by phosphoflow cytometric determination of p70S6 kinase activity. Hoerning A; Wilde B; Wang J; Tebbe B; Jing L; Wang X; Jian F; Zhu J; Dolff S; Kribben A; Hoyer PF; Witzke O Transplantation; 2015 Jan; 99(1):210-9. PubMed ID: 25099702 [TBL] [Abstract][Full Text] [Related]
3. Assay validation of phosphorylated S6 ribosomal protein for a pharmacodynamic monitoring of mTOR-inhibitors in peripheral human blood. Dieterlen MT; Bittner HB; Klein S; von Salisch S; Mittag A; Tárnok A; Dhein S; Mohr FW; Barten MJ Cytometry B Clin Cytom; 2012 May; 82(3):151-7. PubMed ID: 22213594 [TBL] [Abstract][Full Text] [Related]
4. Phosphorylation of p70S6 kinase predicts overall survival in patients with clear margin-resected hepatocellular carcinoma. Baba HA; Wohlschlaeger J; Cicinnati VR; Hilgard P; Lang H; Sotiropoulos GC; Takeda A; Beckebaum S; Schmitz KJ Liver Int; 2009 Mar; 29(3):399-405. PubMed ID: 18492014 [TBL] [Abstract][Full Text] [Related]
5. Leucine induces phosphorylation and activation of p70S6K in cortical neurons via the system L amino acid transporter. Ishizuka Y; Kakiya N; Nawa H; Takei N J Neurochem; 2008 Jul; 106(2):934-42. PubMed ID: 18435829 [TBL] [Abstract][Full Text] [Related]
6. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats. Hu LY; Sun ZG; Wen YM; Cheng GZ; Wang SL; Zhao HB; Zhang XR Neuroscience; 2010 Sep; 169(3):1046-62. PubMed ID: 20678995 [TBL] [Abstract][Full Text] [Related]
7. Thiazolidinediones inhibit insulin-like growth factor-i-induced activation of p70S6 kinase and suppress insulin-like growth factor-I tumor-promoting activity. He G; Sung YM; Digiovanni J; Fischer SM Cancer Res; 2006 Feb; 66(3):1873-8. PubMed ID: 16452250 [TBL] [Abstract][Full Text] [Related]
8. P70S6 kinase phosphorylation: a new site to assess pharmacodynamy of sirolimus. Wang JY; Fan H Chin Med J (Engl); 2015 Mar; 128(5):664-9. PubMed ID: 25698201 [TBL] [Abstract][Full Text] [Related]
9. Biochemical monitoring of mTOR inhibitor-based immunosuppression following kidney transplantation: a novel approach for tailored immunosuppressive therapy. Hartmann B; Schmid G; Graeb C; Bruns CJ; Fischereder M; Jauch KW; Heeschen C; Guba M Kidney Int; 2005 Dec; 68(6):2593-8. PubMed ID: 16316335 [TBL] [Abstract][Full Text] [Related]
10. The PI3K/Akt and mTOR/P70S6K signaling pathways in human uveal melanoma cells: interaction with B-Raf/ERK. Babchia N; Calipel A; Mouriaux F; Faussat AM; Mascarelli F Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):421-9. PubMed ID: 19661225 [TBL] [Abstract][Full Text] [Related]
11. A spectrophotometric assay for routine measurement of mammalian target of rapamycin activity in cell lysates. Dekter HE; Romijn FP; Temmink WP; van Pelt J; de Fijter JW; Smit NP Anal Biochem; 2010 Aug; 403(1-2):79-87. PubMed ID: 20417611 [TBL] [Abstract][Full Text] [Related]
12. Refeeding and insulin activate the AKT/p70S6 kinase pathway without affecting IRS1 tyrosine phosphorylation in chicken muscle. Duchêne S; Métayer S; Audouin E; Bigot K; Dupont J; Tesseraud S Domest Anim Endocrinol; 2008 Jan; 34(1):1-13. PubMed ID: 17029674 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the mammalian target of rapamycin pathway and the effect of rapamycin on target expression and cellular proliferation in osteosarcoma cells from dogs. Gordon IK; Ye F; Kent MS Am J Vet Res; 2008 Aug; 69(8):1079-84. PubMed ID: 18672974 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the mammalian target of rapamycin signalling pathway in extramammary Paget's disease. Chen S; Nakahara T; Uchi H; Takeuchi S; Takahara M; Kido M; Dugu L; Tu Y; Moroi Y; Furue M Br J Dermatol; 2009 Aug; 161(2):357-63. PubMed ID: 19438435 [TBL] [Abstract][Full Text] [Related]
16. Rapamycin reverses NPM-ALK-induced glucocorticoid resistance in lymphoid tumor cells by inhibiting mTOR signaling pathway, enhancing G1 cell cycle arrest and apoptosis. Gu L; Gao J; Li Q; Zhu YP; Jia CS; Fu RY; Chen Y; Liao QK; Ma Z Leukemia; 2008 Nov; 22(11):2091-6. PubMed ID: 18685609 [TBL] [Abstract][Full Text] [Related]